Axxion S.A.’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$770K Hold
12,332
– – 0.05% 178
2026
Q2
$711K Buy
+12,332
New +$708K 0.05% 189

Other funds holding BMY

Axxion S.A.'s BMY Position: Q3 2026 in Review

Axxion S.A. held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 12,332 shares worth $770K. The position accounts for 0.05% of the portfolio, ranked #178.

Axxion S.A. first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 2,437 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Axxion S.A. held 12,332 shares of Bristol-Myers Squibb worth $770K as of Q3 2026.
  • Axxion S.A. left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.05% of Axxion S.A.'s portfolio in Q3 2026, its #178 holding.
  • Axxion S.A. first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
  • 2,437 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.